The Eli Lilly drug reduces the mysterious LP particle (a) involved in the risk of heart attack
About one in five people - about 64 million in the United States - have high levels of a small particle in the blood. It can significantly increase the risk of heart attacks and blows.But few know it, and almost no doctor feels it, because there was not much to do. The diet does not help. Not even the exercise. There were no drugs.But in the near future, this could change.On Sunday, cardiologists have announced that an experimental drug made by Eli Lilly, Lepodisiran, could reduce the levels of particle, LP (A), of 94 percent with a single injection. The effects lasted for six months and there have been no significant side effects.But it is not yet confirmed that the reduction of LP levels (A) also reduces the risk of heart attacks and shots. This awaits large clinical studies that are now...